NASDAQ:ATRA
Atara Biotherapeutics Inc
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.atarabio.comipo date
Oct 16, 2014
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematolog...Show More
Earnings
Earnings Release in 10 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus